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Summary 
The MRL-lpr/Ipr mouse strain is a model of systemic autoimmune disease. In this model, intrinsic 
defects of intrathymic T cell development include defective deletion of self-reactive T cells and 
expression of endogenous retroviruses. Defective deletion of self-reactive T cells in the thymus 
has been proposed to be due to a germline mutation in the Fas apoptosis gene. Using different 
fragments of a Fas cDNA probe, we determined that the Ipr/lpr mutation is a 5.3-kb insertion 
of DNA within the second intron of the Fas gene. cDNA corresponding to this region was 
then derived from thymic RNA from MRL-Ipr/Ipr and MRL- +/+  mice using the polymerase 
chain reaction. All thymic KNA samples from MRL-Ipr/lpr mice yielded a unique product that 
was 168 bp larger than that of MRL- +/+ mice. Complete sequence analysis indicated that this 
inserted sequence had 98% homology with a sequence from the 3' long terminal repeat of the 
early transposon  (Egh). RNA analysis indicated higher expression of E~ KNA in the thymus 
of MRL-Ipr/lpr than MRL- +/+  mice. The interdependence of ETn expression and abnormal 
Fas expression was then analyzed in a CD2-Fas transgenic mouse model in which a fuU-length 
murine Fas cDNA under the regulation of the CD2 promoter and enhancer was used to correct 
defective  Fas expression  in T cells of MtLL-IF/I  F  mice. In these mice, reduced thymic  E~ expression 
was observed, confirming that high E~ expression is rdated to abnormal Fas expression. These 
results establish a link between endogenous retrovirus expression, abnormal Fas expression, and 
autoimmune disease. 
T 
he homozygous expression of the Ipr/lpr gene leads to 
autoimmunity and lymphadenopathy  in different strains 
of  mice, including MKL, C57BL/6, C3H, AKR, and BALB/c 
(1). The Ipr gene has been identified as a point mutation in 
the intracellular region of the Fas gene in CBA/J-Iprr  mice 
(2). The functional significance of this point mutation has 
been demonstrated in transfection studies using a normal in- 
tracellular region of the Fas gene, or an intracellular domain 
containing this point mutation, ligated to the extracellular 
domain of the human Fas gene. After transfection into L929 
cells and Fas crosslinking of the expressedJas molecules with 
anti-human Fas antibody, apoptosis occurred in cells trans- 
fected with the normal chimeric Fas gene, but not in cells 
expressing the chimeric Fas gene using the mutated intracel- 
lular domain (2).  The Fas gene also has been found to be 
abnormal in MKL-Ipr/Ipr mice in which Southern blot anal- 
ysis indicated altered restriction enzyme digestion (2, 3) and 
Fas R.NA expression was not detectable in the thymus (2). 
These results led to the conclusion that the Fas mutation in 
MRL-Ipr/lpr mice was different from the mutation in CBA/ 
J-lprcs mice,  and that  in MRL-Ipr/lpr  mice the mutation 
leads to disruption of normal transcription  of the Fas gene. 
Different strains of Ipr/Ipr mice develop different types of 
lymphoproliferative autoimmune disease (1). Genetic differ- 
ences between the different strains of Ipr/Ipr mice play a role 
in determining the levels in autoantibody production, the 
type and severity of autoimmune disease, and extent of lym- 
phoproliferation  (1, 4, 5). Genes determining the severity of 
renal disease in mice expressing the Ipr/Ipr gene have been 
mapped to chromosomes 7 and 12, whereas genes associated 
with arthritis,  although known to exist, have not yet been 
mapped (3-5). The heterozygous expression of the Ipr gene 
also leads to a less severe  form of lymphoproliferative autoim- 
mune disease (6). It is not yet known if these disease differ- 
ences are related to differences in expression of the Fas gene, 
or to the influence of other genes in the immune response. 
We have previously reported that the Fas mutation was 
due to the insertion of a retrotransposon in the Fas gene (7). 
This  early  transposon  (ETn) 1 was  found  to  be  inserted 
within transcripts of the otherwise normal Fas gene. At least 
two abnormal sized transcripts of the Fas gene contained tran- 
1 Abbreviation used in this paper: ETn, early  transposon. 
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sequence inserted between the second and third exon. In ad- 
dition, there was a larger ETn.Fas transcript of '~10.5 kb. 
In this paper we have confirmed our previous findings and 
have further characterized the ETn sequence within the second 
intron of the Fas gene in MRL-lpr/Ipr mice. This mutation 
leads to the abnormal transcription and splicing of the Fas 
gene in MRL-Ipr/Ipr mice, and results in reduced amounts 
of normally spliced Fas mRNA (2%). The expression of ETn 
is increased  in the thymus of younger mice, but decreases 
with age.  In addition, in CD2-Fas transgenic MRL-Ipr/lpr 
mice, increased expression ofFas mKNA results in decreased 
expression of ETn in the thymus. These results indicate that 
the extent of interruption of the Fas transcription by ETn 
is not constant, and that Fas transcription is less disrupted 
under conditions that suppress expression  of the ETn retro- 
transposon. 
Materials  and Methods 
Normal Mice.  The original breeding pairs of MRblpr/lpr and 
MR.b+/+ mice  were obtained from The Jackson Laboratory (Bar 
Harbor, ME). 
Production of CD2-Fas Trunsgenic  MRL.lpr/lpr Mice.  The 1.1-kb 
full-length  Fas cDNA was obtained  by PCK amplification  of  cDNA 
made from thymus mRNA from MR.b+/+  mice as described 
brow. This was cloned into an EcoKI site in front of exon 1 of 
a human CD2 minigene  consisting  of 5.5 kb of  5' flanking sequence, 
emn 1, the first intron, fused  e~ons  2-5, and 2.1 kb of the 3' flanking 
sequence. The Y sequence has been shown to be sufficient  to allow 
T cell-spedfic, copy-dependent, integration-independent expres- 
sion in transgenic mice (8, 9). MRL-Ipr/Ipr male and female mice 
were obtained  from The Jackson Laboratory.  Single-cell  MRL-Ipr/Ipr 
embryos were produced, injected with ,,o100 copies of the CD2- 
Fas transgene, and then place into the distal oviduct of CD1 pseu- 
dopregnant female mice. Tail DNA prepared from offspring was 
digested with EcoKI and probed with a 32P-hbeled full-length Fas 
cDNA to identify CD2-Fas transgenic mice (Wu, J., T. Zhou, J. 
Zhang, J. He, and J. D. Mountz, manuscript in preparation). 
Southern Blot Analysis.  MILL-Ipr/Ipr  and MRD +/+ mice  were 
obtained from The Jackson Laboratory. DNA was prepared from 
the thymus and digested with the indicated restriction enzymes. 
Approximately  10 #g of  the digested  DNA was separated  on a 0.7% 
agarose gel, blotted to a nylon membrane, and hybridized with 
32p-labeled cDNA probes. 
Northern Blot Analysis.  RNA was prepared as described previ- 
ously (10). 5 #g of poly(A)  + KNA was denatured at 65~  for 5 
rain in dectrophoresis buffer (0.4 M 3-morpholinopropanesulfonic 
acid, 0.1 M sodium acetate, 2 mM EDTA pH  =  7.0) containing 
6% formaldehyde and 50% formamide, and size fractionated by 
electrophoresis through 1% agarose gels containing 0.6% formal- 
dehyde. Gels  were stained  with ethidium bromide to assure  integrity 
of the loaded KNA. RNA was transferred to nylon membranes 
(Nitroplus 2000; Micron Separations  Inc., Eastboro, MA) and baked 
for 2 h at 80oC in a vacuum oven. Membranes were prehybridized 
and then hybridized with 1-3  x  106 cpm/ml of different DNA 
probes that had been hbeled with 3zp by random priming to a 
specific activity of 109 cpm/#g. Filters were then washed with 2x 
SSC  +  0.1% SDS at 42~  for 30 min and then with 0.1x  SSC 
+ 0.1% SDS at 60~  for 30 min; they were then exposed  to XAK-2 
film (Eastman Kodak, Rochester,  NY) at - 70~  with intensifying 
screens. 
PCR Analysis.  Thymuses  of mice were homogenized and total 
RNA was extracted from the homogenates by the guanidinium- 
CsCI method. Total RNA (2-4/~g) from each tissue was used for 
cDNA synthesis followed by PCR amplification using an KNA- 
PCR kit (Perkin-Elmer  Corp., Norwalk, CT). Reaction conditions 
were as specified  by the manufacturer. An oligo(dT) primer was 
used to initiate cDNA synthesis. 30 PCR cycles (1 min at 95~ 
1.5 min at 55~  2.5 min at 72~  were run followed  by extension 
for 10 min, and the amplification products were visualized after 
electrophoresis on agarose gels (1.0%) under ultraviolet illumina- 
tion in the presence of ethidium bromide. Gels were blotted and 
hybridized to a labeled internal Fas probe to verify that the bands 
were Fas specific.  The fuU-length  Fas cDNA was obtained by PCR 
amplification  of  cDNA made from thymus mRNA and MILblpr/Ipr 
or MRD+/+  mice. The full-length cDNA PCR primers were 
(Pl, 5'-GGC-CGC-CCG-CTG-TT~I:FCC-CTT-GCT-GCA-GAG  - 
3'; position  +20)  and (P4, 5'-ATT-GAC-ATT-GGC-AAC-TCC- 
TGG-TGT-Y; position 1110). Internal primers were used to obtain 
the extracellular  domain cDNA that was sequenced. These primers 
were (P2, 5'-CA-CAG-TTA-AGA-GTT-CAT-ACT-CAA-GGT-ACT- 
AAT-Y; position +93) and (P3, 5'-AA-AGT-CCC-AGA-AAT-CGC- 
CTA-TGG-TTG-TTG-Y; position  540).  5'  primers used in  se- 
quencing were the universal  vector 5' primer: (5'-CTG-TGG-ATC- 
TGG-GCT-Y; position 53), (5'-TGT-CAA-CCA-TGC-CAA-CCT- 
Y; position 215), (5'-CGA-AAG-TAC-CGG-AAA-AGA-Y;  position 
608), and (5'-CGA-GAA-AAT-AAC-ATC-AAG-Y;  position 773). 
3' primers used in sequencing were the 3' universal vector primer: 
(5'-GAA-TCT-AGA-ACC-TCC-AGT-Y; position  656), (5'-TGT- 
GTT-CGC-TGC-GCC-TCG-Y; position  464), (5'-ACA-GAA- 
GGG-AAG-GAG-TAC-Y; position 293), and (5'-GTT-GAG-GAC- 
TGC-AAA-ATG-Y; position 245). Sequence  positions  are referenced 
to the published murine Fas sequence (11). 
Genomic Cloning.  High  molecular weight  DNA  from  the 
thymus of MtLblpr/lpr and MKI_,+/+  mice was digested with 
PstI and HincII. The digested sample was divided  into several  wells 
and subjected  to electrophoresis through 0.8% agarose. After elec- 
trophoresis, a portion of the gel was blotted and probed with the 
345-bp HincII fragment of Fas and the 168-bp ETn fragment, and 
another portion of the gel was sliced  into thin sections  representing 
different molecular weights. The gel slices corresponding in size 
to bands hybridizing with the Fas or ETn probes were extracted 
from the gel using Geneclean II (Bio 101, La Jolla, CA). DNA 
fragments ranging from 3.8 to 5.6 kb were amplified using the 
appropriate Y or 5' Fas cDNA primers in combination with ETn 
primers from the 168-bp sequence (see Fig. 2) and published ETn 
sequences (12). PCK products  were doned into the PCK 2000 vector 
(Invitrogen, San Diego, CA) for sequence analysis. 
Sequence Analysis.  Sequence  analysis  was carried out on double- 
stranded DNA derived from PCK amplification and cloning into 
the PCK 2000 (Invitrogen). Sequence analysis was carried out in 
both directions using 5' and 3' universal primers and Fas-specific 
primers. For genomic sequencing, universal primers were used to 
determine the sequence of both the 3' end of the second exon and 
the 5' end of the third exon and flanking intronic sequences. 
DNA Probes.  The full-length  murine Fas cDNA probe (49-1033 
bp) was derived by PCK amplification of cDNA prepared from 
MKb+/+  thymus mRNA as described above and using previ- 
ously described Fas primers (11). A probe corresponding to the first 
and second exons of Fas, which are 5' of the normal ETn insertion, 
was the 170-bp PstI-HinclI fragment (49-219 bp) derived  from the 
full-length Fas cDNA clone (Fig. 2 a). A probe corresponding to 
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fragment (219-569 bp) derived from the fuU-length  Fas cDNA clone. 
The ETh probe was the 168-bp ETn sequence that was isolated by 
PCR amplification of cDNA prepared from MRL.Ipr/Ipr thymus 
mRNA and reamplified using  primers  specific for the 5' and 3' 
sequences of  ETn. The/3-actin probe was a gift from Dr. K. Gordon 
(GenZyme Corp.,  Framingham,  MA) (13). 
Results 
The Ipr Mutation Results from a 5.3-kb Insertion of DNA. 
High molecular weight DNA from the kidney and thymus 
of MRL-Ipr/Ipr and MILL- +/+  mice was digested with var- 
ious restriction enzymes and probed with a 345-bp sequence 
corresponding to the extracdlular domain of the Fas cDNA 
(Fig.  1 a).  There was no difference in restriction  fragment 
lengths between high molecular weight DNA from the kidney 
and the thymus (data not shown).  There was an additional 
5.3 kb of  DNA within the extracellular domain of the genomic 
Fas gene from MRL-Ipr/lpr mice as determined by restric- 
tion fragment length analysis of Southern blots prepared using 
multiple  single and double enzyme digestions  and hybrid- 
ization with a 170-bp cDNA probe corresponding to the first 
and second exons ofFas cDNA (49-219 bp), an extracellular 
domain probe (219-569 bp), and a full-length Fas cDNA probe 
(49-1033 bp). The inserted DNA contained additional diges- 
tion sites for EcoRI, HindIII, and PvuII but not for BamHI 
(Fig.  1 b).  Using probes corresponding  to exons  1 and 2, 
or a HincII cDNA fragment corresponding to the extracel- 
lular domain,  the insert was localized to the region of the 
Fas gene corresponding  to  the  second intron  (Fig.  1 b). 
Insertion of ETn in the Extracelhlar Domain of Fas cDNA 
from Ipr/Ipr Mic~  To determine  if the Ipr/Ipr mutation  in 
the extracellular domain of the Fas gene results in abnormal 
Fas RNA, cDNA corresponding to the extracdlular domain 
was derived from thymus  RNA from several MRL-Ipr/Ipr 
and MRL- +/+  mice using the PCK and primers  P2 and 
P3 (Fig. 2 a). All RNA samples from the thymus of different 
MRL-lpr/lpr mice yielded a unique PCK product that  was 
168  bp  larger  than  that  of wild-type  MRL-+/+  mice 
(Fig. 2 b). The mutation of the Fas gene in MRL-Ipr/lpr mice 
was confirmed to be in the extraceilular domain by sequencing, 
using full-length primers P1 and P4 (Fig.  2 a) and using the 
extracellular Fas cDNA clones from MRL-lpr/Ipr and MILL- 
+/+  mice. The sequence of the transmembrane and cytoplas- 
mic domains were identical in MRL-lpr/lpr and MRL- +/+ 
mice.  Complete sequence analysis  of cDNA corresponding 
to the extracellular domain of the Fas gene was carried out 
using two different MRL-Ipr/Ipr mice and indicated that there 
was a 168-bp insert into the Fas cDNA sequence at position 
232 of an otherwise normally encoded extracellular domain 
(11) (Fig.  2 c).  The 268-bp ETn sequence found within the 
Fas gene was 99% homologous to sequence Mus ETn Xi (12, 
14) (base pairs 1120-1285) and Mus ETn IgM (15) (base pairs 
270-435)  as determined  by searching  GenBank. 
Fas Gene Expression in lpr and  +/+  Mice.  A  full-length 
Fas cDNA was used to probe Northern blots ofpoly(A) KNA 
prepared  from  the  thymus  of MRL-+/+,  MRL-Ipr/lpr, 
Figure  1.  Southern blot analysis of the Fas gene in MRL-Ipr/Ipr  and 
wild-type MR.b+/+  mice. DNA was purified from thymuses of wild- 
type  MILL-+/+ (+) and MRblpr/Ipr  (L) mice. (a) High molecular  weight 
DNA was digested  with the indicated restriction enzyme  and probed  with 
a HinclI cDNA fragment corresponding to the extracellular  domain frag- 
ment extending from 219 to 569 bp of the routine sequence. (b) Restric- 
tion map derived by single and multiple double enzyme digestions, and 
probing with a cDNA fragment corresponding to either a 170-bp Pstl- 
HinclI cDNA fragment (+49 to  +219 bp), which is entirely 5' of the 
ETn insertion, a probe  corresponding to the remainder of the extracelhlar 
domain, which was a 345-bp HinclI cDNA fragment (+219 to  +569 
bp), or the fuU-length  Fas cDNA probe  (+ 49 to + 1033 bp). The location 
of the 5.3-kb inserted DNA and the approximate location of Exl, Ex2, 
and Ex3 were  derived  using the different  probes  on multiple identical blots. 
Additional enzyme  sites  present in the 5.3-kb insert are indicated. R, EcoRI; 
B, BamHl; H, HindllI; P, PvulI. 
MRL-Ipr/+,  BXSB  male,  and  NZB  mice  and  from  the 
BW5147 cell line.  In MRL-+/+  mice there was a 2.2-kb 
normal-sized Fas cDNA (Fig. 3 a, lane 1-3).  In contrast, in 
1-mo-old MRL-Ipr/Ipr mice there were multiple bands ranging 
from 2 to 10.5  kb (Fig.  3 a,  lanes  4 and 6). Fas expression 
was highest in the thymus of 1-mo-old MKL-lpr/Ipr mice, 
and decreased in 3-mo-old mice (Fig. 3 a, lane 5). When iden- 
tical blots were hybridized with  a  170-bp PstI/HinclI Fas 
cDNA fragment corresponding to the first and second exons, 
Fas expression in MRL-lpr/Ipr mice was very low compared 
with Fas expression in MRL- +/+  mice (Fig. 3 b, lanes 4-6). 
A faint abnormal high molecular weight species of 10.5 kb 
was present using this 5' probe (Fig. 3 b, lane 4, arrow). When 
blots were probed with a 345-bp HincII Fas cDNA fragment 
corresponding  to  the extraceUular domain  of Fas, the pri- 
mary species of RNA expressed in the thymus of young MRL- 
Ipr/Ipr mice was a high molecular weight  10.5-  and 9.5-kb 
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ETn. (a) The position of the E~  sequence inserted within the F-as  gene 
was determined by sequence analysis of eDNA prepared from the thymus 
of MRh.lpr/lpr and MILL-+/+  mice. The PCK primers used and their 
relative locations within the Fas gene are indicated as Pl, P2, P3, and P4. 
Also shown is the location of the 170-bp 5' probe, which is the PstI-HincII 
fragment, and the 345-bp extraceUular domain probe, which is the HinclI 
fragment derived from the normal Fas eDNA done. (b) The PCK prod- 
ucts using primers P2 and P3 were subjected to agarose gel ehctrophoresis 
and visualized  by ultraviolet illumination in the presence of ethidium bro- 
mide. A unique larger PCK product was observed using thymic KNA 
from six different  MKblpr/Ipr  mice.  (c) The wild-type sequence of the 
Fas gene is numbered as previously described (11). The ETn sequence found 
within the otherwise normal extracellular coding region of Fas eDNA 
from MILL-lpr/Ipr  mice is 98% homologous to a portion of an ETn previ- 
ously found to be integrated into the Ig locus of mice (12, 14, 15). The 
168-bp ETn insert in the Fas gene of MKL-Ipr/lpr mice results in an in- 
frame amino acid sequence  shown below the eDNA sequence. 
transcript (Fig. 3 c). These results indicate that the Fas muta- 
tion leads to production of abnormal high molecular weight 
Fas transcripts in the thymus. There was high expression  of 
the 2.2-kb Fas transcript in (MRL-Ipr/Ipr x  MILL- +/+ )Ft 
mice,  and also in BXSB male and NZB  autoimmune mice 
(Fig.  3, a-c;  lanes  7-9).  Expression  of normal levels of/=as 
RNA in BXSB  and NZB mice indicates  that  autoimmune 
disease in these mice is not related to  defective  expression 
of Fas KNA. 
The 168-bp ETn probe, derived from within the Fas cDNA 
prepared from thymus KNA of MRL-lpr/Ipr mice, strongly 
hybridized  to a 5.7-kb  full-length E~  transcript  that  was 
Figure  3.  Northern blot analysis  ofF-as  RNAs from the thymus of wild- 
type MKL-+/+  and MKl..lpr/llor mice. Thymus poly(A)  + RNA from 
the indicated mouse strains was analyzed by probing four identical blots 
with: (a) a full-length Fas eDNA probe, (b) a 5' Pst-I/HinelI Fas eDNA 
probe corresponding to position 49-219,  (c) a Fas eDNA probe corre- 
sponding to the 345-bp HinclI fragment of extracellular domain, and (d) 
a 168-bp ETn probe derived from E~ sequences within the abnormal sized 
Fas transcript obtained by PCR amplification of the extracellular domain 
Fas eDNA from lpr/lpr mice. MILL-+/+, BXSB male, and NZB female 
mice were 2 mo of age. MRL-lpr/Ipr mice were 1 mo old (lanes 4 and 
6) and 3 mo old (lane 5).  (a-c) Arrows indicate the abnormal Fas tran- 
scripts in MRL-Ipr/lpr mice that correspond in size to a unique transcript 
that also hybridizes to the ETn probe used in d. 
expressed in the thymus of younger MRL-Ipr/lpr mice (Fig. 
3 d, lanes 4 and 6), but not strongly expressed in the thymus 
of older MRL-Ipr/Ipr  mice (Fig. 3 d, lane 5) or in the thymus 
ofMRL- +/+  mice (Fig. 3 d, lanes 1-3). RNA corresponding 
to the fuU-length 5.7-kb E~  transcripts was also abundant 
in the thymus of MRL-Ipr/+  and BXSB mice,  and also in 
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Figure  4.  Sequence  analysis  of 
the ETn in the germline Fas gene. 
(To/,) The 168-bpETn insert, which 
is aberrantly spliced between exons 
2 and 3 in some of the Fas transcripts 
in MR~Ipr/Ipr mice. (Middle) The 
short 14-bp germline sequence be- 
tween exon 2 and the 168-bp E~ 
transcript within Fas, followed by 
an addition of '~5.3 kb of ETn se- 
quence  and then by 3.5 kb of in- 
tron sequence. (Bottom) The 5.3 kb 
of ETn sequence that is integrated 
into the second  intron of the Fas 
gene of MRL-Ipr/lpr mice. 
the BW5147 cell line. The largest Fas transcript corresponds 
in size to an abnormal 10.5-kb ETn transcript in MRL-Ipr/Ipr 
mice (Fig. 3, a-d, lanes 4, arrows), suggesting the presence 
of the ETn sequence within one of the abnormal-sized high 
molecular weight Fas transcripts  of MRL-Ipr/Ipr  mice. A 
higher ~10.5-kb molecular weight Fas transcript  was also 
present in the thymus of MRL-Ipr/+  and BXSB mice, but 
not NZB mice or the BW5147 cell line (Fig. 3 a, lanes 7-10). 
Germline Organization of the Mutated Fas Gene in lpr Mice. 
Using PCR primer pairs to the 3' end of Fas exon 2 and 
the 5' end of the 168-bp ETn found in the Fas transcript  or 
the 5' end ofFas exon 3 and the 3' end of ETn, the sequences 
of  cloned genomic fragments isolated using the 345-bp HinclI 
fragment of Fas and the 168-bp ETn fragment were deter- 
mined (Fig. 4). In MRL-Ipr/Ipr mice the ET~ sequence began 
at the 5' terminal of exon 2 and continued for an additional 
5.3 kb. There was a conserved splice consensus nucleotide 
sequence on the 3' end of exon 2-intron 2 (G/A) and on the 
5' end of  the 168-bp ET~ (A/G), which was found to be spliced 
into the Fas transcript. Also, there was a conserved splice con- 
sensus at the 3' end of the 168-bp ETn (A/G) and on the 
5' end of the Fas exon 3 (A/G). These splice consensus se- 
quences allow for splicing of the 168-bp ETn into the Fas 
cDNA. Additional ETn sequence was present in the MRL- 
Ipr/Ipr mice directly  adjacent to the 3' terminus of the second 
exon (Fig. 4).  In MKL-+/+  and MRL-lpr/Ipr mice there 
was an additional 3.5 kb of intron sequence consistent with 
the restriction map shown in Fig.  1. 
Downregulation of  ETn in a CD2-Fas Transgenic  MRL-lpr/Ipr 
Mice.  To determine if high ET~ expression was dependent 
on abnormal Fas expression, CD2-Fas transgenic mice were 
produced that used a full-length murine Fas cDNA under 
the regulation of the CD2 promoter and enhancer (8, 9) to 
correct defective  Fas expression in T cells of MRL-Ipr/Ipr mice. 
The presence of the Fas transgene resulted in reduction of 
expression of ETn in the thymus, suggesting that high ETn 
expression is related to abnormal Fas expression (Fig. 5 A). 
Northern blot analysis indicated that there was high expres- 
sion of the Fas transgene  in the thymus and lymph node, 
but not in the brain of 4-wk-old CD2-Fas transgenic MRL- 
Ipr/Ipr mice (Fig.  5 B). 
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Discussion 
Watson et al. (3) previously reported that there was a 1.4- 
kb deletion near the BamHI site of the Fas gene. Restriction 
map analysis and intron sequencing described in the present 
paper indicate that there is a 5.3-kb insert containing the ETn 
retrotransposon. The discrepancy  between our resuks and the 
previous results may be related to our use of  a greater number 
Figure  5.  Decreased E~ expression in CD2-Fas transgenic MRL-Ipr/lpr 
mice. Poly(A) KNA from thymus, lymph node (LN), and brain of 4-wk- 
old CD2-F~s transgenic and nontransgenic MKL-Ipr/lpr  mice was blotted 
as described in Fig. 3.  (A) ETn expression is decreased in the thymus of 
4-wk-old CD2-Fas Transgenic  MRLlpr/lpr  mice but not in age-matched 
nontransgenic littermate control mice. (B) CD2-Fas transgenic MKIAlx/lpr 
mice have high levels ofFas KNA in the thymus and LN but not in non-T 
cell sites, including the brain. Nontransgenic litter mate control mice do 
not express Fas. (C) The blot was stripped and hybridized with a fl-actin 
probe to ensure  that nearly equal amounts of RNA were present in all 
samples. of restriction enzymes, including HindlII and BanlI, which 
has a restriction site in ETn (Fig. 1), and HinclI and PstI (data 
not shown). It is unlikely that there is a difference in the 
mice, since both analyses were carried out on MRL-Ipr/Ipr 
mice obtained from The Jackson Laboratory. 
ETn retrotransposon transcription occurs during early em- 
bryonic development in mice (16, 17). Increased expression 
of endogenous retroviruses in the thymus of autoimmune 
strains  has been proposed to be related  to development of 
autoimmune disease (18-20).  In this paper, we report that 
there is also increased expression of full-length E~ endoge- 
nous retrovirus in the thymus of MRL-Ipr/lpr mice and BXSB 
mice (Fig. 3). Inhibition of translation of retroviral transcripts 
by antisense KNA has been reported to result in increased 
proliferation of lymphocytes leading to the speculation that 
full-length retroviral  transcripts and protein products are a 
compensatory mechanism for increased lymphocyte prolifer- 
ation in autoimmune mice (18). A second mechanism of as- 
sociation of retroviruses with autoimmunity is suggested by 
the present data, which suggest that increased retroviral ex- 
pression may be related to defective Fas expression in MRL- 
lpr/lpr mice. 
The ETn retrotransposon in the second intron of the Fas 
gene might interfere with Fas expression by promoting ab- 
normal transcription initiation and interfering with abnormal 
splicing.  High expression  of ETn correlates  with high ex- 
pression of an abnormal large-sized Fas transcript with a mo- 
lecular weight of "~10.5 kb (Fig. 3, lanes 4 and 6). The largest 
Fas transcript corresponds in size with an abnormal ETn tran- 
script of the same size. This transcript contains both 5' and 
3' Fas cDNA sequences because it is detected by both the 
5' 170-bp Pst-1/HincII Fas probe and the 3' 345-bp HincII 
Fas probe.  A lower unusual Fas transcript with an approxi- 
mate molecular weight of 7.5 kb, which retains  5' and 3' 
Fas sequences (Fig. 3, lane 4), does not hybridize with the 
168-bp ETn probe, indicating that the 168-bp portion of ETn 
is spliced out of this transcript. Other aberrant splicing events 
can lead to Fas transcripts that contain only 168 bp of ETn 
sequences (Fig. 2). These results suggest that thymic develop- 
mental factors that lead to high E~ expression also promote 
production of an abnormally large Fas transcript in MKL- 
Ipr/lpr mice due to the integration of E~ within the second 
intron of the Fas gene. 
In MRL-Ipr/+ heterozygous mice, there was increased ex- 
pression of ETn and abnormal Fas, despite the presence of 
apparently normal levels of Fas transcription from the un- 
mutated allele. It is possible that abnormal Fas and high ETn 
are expressed in a subpopulation of thymocytes that express 
low levels of normal Fas and exhibit abnormal thymic devel- 
opment. This was investigated in CD2-Fas transgenic MRL- 
Ipr/Ipr mice. In these mice, Fas expression is regulated by the 
CD2 promoter/enhancer, which results in high expression 
of/:as in all thymocytes, and elimination of ETn expression 
(Fig. 5). These results suggest that Fas expression and ETn 
expression  are functionally related. 
We have also observed that ETn expression is decreased 
and Fas expression is partially normalized in TCK-B trans- 
genic mice (Wu, J., andJ. D. Mountz, manuscript in prepa- 
ration). We have previously demonstrated that in TCK-B trans- 
genic mice, there is nearly total elimination of the CD4- 
CD8-B220 +  subpopulation  of  T  cells  and  lympho- 
proliferation, but not elimination of autoimmunity (21, 22). 
We have recently demonstrated that there is decreased apopo- 
tosis of thymocytes of MRL-Ipr/lpr mice and an increase of 
a large, proliferating CD4 +  CD8 + subpopulation of thymo- 
cytes (22). The TCK-B transgene was found to reduce these 
large, proliferating CD4 +  CD8 + thymocytes, and there was 
no difference between this population in TCK-/~ transgenic 
MKL-lpr/Ipr mice and the same population in MRL- +/+ 
mice. These results suggested that the presence of the TCK- 
B transgene corrected the defect in early T cell development 
related to lymphoproliferation  despite the presence of a germ- 
line mutation of the Fas apoptosis gene. Rearrangement of 
the TCK-B chain gene has been proposed to play a critical 
role in early T cell development in the thymus (23, 24). The 
TCR-B transgene suppresses rearrangement of the endoge- 
nous TCK-~ gene (25). Suppression of rearrangement of the 
endogenous TCK-B gene might accelerate T cell maturation 
resulting in decreased levels of retroviral LTK and eukaryotic 
gene enhancer binding proteins associated with T cell devel- 
opment (26). Prevention of aberrant transcription initiation 
at the site of the ETn integration within the second intron 
of the murine Fas gene could result in normal transcription 
initiation from the 5' end of the Fas gene. This would lead 
to the observed increased levels of Fas expression in the thymus 
of the TCK-~ transgenic MP,  L-lpr/Ipr mice. This interpre- 
tation is consistent with the concept that ETn expression and 
abnormal Fas expression are functionally related in Ipr mice. 
Abnormal Fas expression  and T  cell development in the 
thymus of autoimmune mice might lead to continued high 
expression of retroviruses.  Abnormal populations of T cells, 
or B cells found in the periphery of autoimmune mice, ex- 
hibit common features of developmental defects and retrovirus 
expression.  In the case of the Ipr/lpr  gene the present data 
suggest that retrovirus expression is intimately related to ab- 
normal Fas gene transcription and abnormal lymphocyte de- 
velopment. For other autoimmune strains of mice, there is 
no evidence for such a direct association of retrovirus expres- 
sion and altered expression of genes related  to autoimmu- 
nity. For the CBA/J-lpr r  mice, the genetic defect of the Fas 
gene is a single point mutation in the cytoplasmic signaling 
region of the gene, and currently there is no evidence to sug- 
gest that this is related to the presence of the ETn retrotrans- 
poson within this gene. It will be necessary to characterize 
the genomic organization of the Fas gene in CBA/J-lpr~g 
mice to determine if a retrovirus might result in abnormal 
splicing and this point mutation. Likewise, cloning and char- 
acterization of defective autoimmune genes in other strains 
of mice, including gld/gld, NZB, and BXSB, will be neces- 
sary to determine if retroviruses play a critical role in abnormal 
expression of autoimmune genes other than the Fas gene. 
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